The Retina Radar with Dr. Arshad Khanani

The Retina Radar with Dr. Arshad Khanani

Podcast

The Retina Radar Season 4 With Dr. Arshad Khanani: Clinical Trials at the Summit 2026 With Drs. David Boyer and Anat Loewenstein

This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 30 mins
  • 0.50 CME
Podcast

The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in nAMD Management in 2026 With Dr. Yasha Modi

This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 30 mins
  • 0.50 CME
Podcast

The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in DME Management in 2026 With Dr. Margaret Chang

This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 30 mins
  • 0.50 CME
Podcast

The Retina Radar Season 4 With Dr. Arshad Khanani: What’s New for RVO in 2026? With Dr. Ehsan Rahimy

This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 30 mins
  • 0.50 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: 2025 Year in Review With Dr. Frank Holz

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 15 mins
  • 0.25 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: Anesthesia for Intravitreal Injections With Dr. John Kitchens

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 15 mins
  • 0.25 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: Surgical Techniques and Instrumentation With Dr. Aleksandra Rachitskaya

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 15 mins
  • 0.25 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: Macular Telangiectasia With Dr. Glenn Jaffe

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 15 mins
  • 0.25 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: Tyrosine Kinase Inhibitors in 2025 With Drs. Chang and Emanuelli

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 15 mins
  • 0.25 CME
Podcast

The Retina Radar With Dr. Arshad Khanani: Going Beyond Anti-VEGF in 2025 With Dr. Ashkan Abbey

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Oculis; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.

  • 30 mins
  • 0.50 CME